Global Salmonella Testing

Salmonella Testing Comprehensive Study by Type (Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, Differential Light Scattering), Application (Hospitals, Public Health Labs, Physician Offices, Commercial/Private Labs) Players and Region - Global Market Outlook to 2026

Salmonella Testing Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Salmonella Testing Market Overview:
Salmonella testing methods include traditional and rapid detection methods. It takes 3 to 5 days to detect the presence of salmonella in a source using the traditional methods, while the rapid detection method takes up to 48 hours to detect the presence of salmonella. The rising prevalence of salmonella infection is by far the leading factor driving the global salmonella testing market.

Growth Drivers
  • Rising Prevalence of Salmonella Infection
  • Implementation of Food Safety Regulations Worldwide along with their Increasing Stringency

Market Trends
  • Rapid Technological Advancements in Testing Procedures

Roadblocks
  • Lack of Proper Food Control Resources

Opportunities
  • Rising Awareness among Consumers regarding Foodborne Diseases
  • Rapid Technological Advancements in Bacterial Detection Technologies

Challenges
  • Lack of Infrastructure in Developing Nations


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Enzo Biochem (United States), Fujirebio (Belgium), Grifols (Spain), Hologic (United States), GSK (United Kingdom), Leica (Germany), Eiken Chemical Company Limited (Japan), Romer Labs (Austria) and Neogen Corporation (United States). Analyst at AMA Research see Global Players to retain maximum share of Global Salmonella Testing market by 2026.

What Can be Explored with the Salmonella Testing Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Salmonella Testing Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Salmonella Testing
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Salmonella Testing market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Salmonella Testing market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Salmonella Testing Manufacturer, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Molecular Diagnostics
  • Monoclonal Antibodies
  • Immunoassays
  • Differential Light Scattering
By Application
  • Hospitals
  • Public Health Labs
  • Physician Offices
  • Commercial/Private Labs
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Salmonella Infection
      • 3.2.2. Implementation of Food Safety Regulations Worldwide along with their Increasing Stringency
    • 3.3. Market Challenges
      • 3.3.1. Lack of Infrastructure in Developing Nations
    • 3.4. Market Trends
      • 3.4.1. Rapid Technological Advancements in Testing Procedures
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Salmonella Testing, by Type, Application and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Salmonella Testing (Value)
      • 5.2.1. Global Salmonella Testing by: Type (Value)
        • 5.2.1.1. Molecular Diagnostics
        • 5.2.1.2. Monoclonal Antibodies
        • 5.2.1.3. Immunoassays
        • 5.2.1.4. Differential Light Scattering
      • 5.2.2. Global Salmonella Testing by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Public Health Labs
        • 5.2.2.3. Physician Offices
        • 5.2.2.4. Commercial/Private Labs
      • 5.2.3. Global Salmonella Testing Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Salmonella Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Enzo Biochem (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Fujirebio (Belgium)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Grifols (Spain)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Hologic (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GSK (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Leica (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Eiken Chemical Company Limited (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Romer Labs (Austria)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Neogen Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Salmonella Testing Sale, by Type, Application and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Salmonella Testing (Value)
      • 7.2.1. Global Salmonella Testing by: Type (Value)
        • 7.2.1.1. Molecular Diagnostics
        • 7.2.1.2. Monoclonal Antibodies
        • 7.2.1.3. Immunoassays
        • 7.2.1.4. Differential Light Scattering
      • 7.2.2. Global Salmonella Testing by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Public Health Labs
        • 7.2.2.3. Physician Offices
        • 7.2.2.4. Commercial/Private Labs
      • 7.2.3. Global Salmonella Testing Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Salmonella Testing: by Type(USD Million)
  • Table 2. Salmonella Testing Molecular Diagnostics , by Region USD Million (2015-2020)
  • Table 3. Salmonella Testing Monoclonal Antibodies , by Region USD Million (2015-2020)
  • Table 4. Salmonella Testing Immunoassays , by Region USD Million (2015-2020)
  • Table 5. Salmonella Testing Differential Light Scattering , by Region USD Million (2015-2020)
  • Table 6. Salmonella Testing: by Application(USD Million)
  • Table 7. Salmonella Testing Hospitals , by Region USD Million (2015-2020)
  • Table 8. Salmonella Testing Public Health Labs , by Region USD Million (2015-2020)
  • Table 9. Salmonella Testing Physician Offices , by Region USD Million (2015-2020)
  • Table 10. Salmonella Testing Commercial/Private Labs , by Region USD Million (2015-2020)
  • Table 11. South America Salmonella Testing, by Country USD Million (2015-2020)
  • Table 12. South America Salmonella Testing, by Type USD Million (2015-2020)
  • Table 13. South America Salmonella Testing, by Application USD Million (2015-2020)
  • Table 14. Brazil Salmonella Testing, by Type USD Million (2015-2020)
  • Table 15. Brazil Salmonella Testing, by Application USD Million (2015-2020)
  • Table 16. Argentina Salmonella Testing, by Type USD Million (2015-2020)
  • Table 17. Argentina Salmonella Testing, by Application USD Million (2015-2020)
  • Table 18. Rest of South America Salmonella Testing, by Type USD Million (2015-2020)
  • Table 19. Rest of South America Salmonella Testing, by Application USD Million (2015-2020)
  • Table 20. Asia Pacific Salmonella Testing, by Country USD Million (2015-2020)
  • Table 21. Asia Pacific Salmonella Testing, by Type USD Million (2015-2020)
  • Table 22. Asia Pacific Salmonella Testing, by Application USD Million (2015-2020)
  • Table 23. China Salmonella Testing, by Type USD Million (2015-2020)
  • Table 24. China Salmonella Testing, by Application USD Million (2015-2020)
  • Table 25. Japan Salmonella Testing, by Type USD Million (2015-2020)
  • Table 26. Japan Salmonella Testing, by Application USD Million (2015-2020)
  • Table 27. India Salmonella Testing, by Type USD Million (2015-2020)
  • Table 28. India Salmonella Testing, by Application USD Million (2015-2020)
  • Table 29. South Korea Salmonella Testing, by Type USD Million (2015-2020)
  • Table 30. South Korea Salmonella Testing, by Application USD Million (2015-2020)
  • Table 31. Taiwan Salmonella Testing, by Type USD Million (2015-2020)
  • Table 32. Taiwan Salmonella Testing, by Application USD Million (2015-2020)
  • Table 33. Australia Salmonella Testing, by Type USD Million (2015-2020)
  • Table 34. Australia Salmonella Testing, by Application USD Million (2015-2020)
  • Table 35. Rest of Asia-Pacific Salmonella Testing, by Type USD Million (2015-2020)
  • Table 36. Rest of Asia-Pacific Salmonella Testing, by Application USD Million (2015-2020)
  • Table 37. Europe Salmonella Testing, by Country USD Million (2015-2020)
  • Table 38. Europe Salmonella Testing, by Type USD Million (2015-2020)
  • Table 39. Europe Salmonella Testing, by Application USD Million (2015-2020)
  • Table 40. Germany Salmonella Testing, by Type USD Million (2015-2020)
  • Table 41. Germany Salmonella Testing, by Application USD Million (2015-2020)
  • Table 42. France Salmonella Testing, by Type USD Million (2015-2020)
  • Table 43. France Salmonella Testing, by Application USD Million (2015-2020)
  • Table 44. Italy Salmonella Testing, by Type USD Million (2015-2020)
  • Table 45. Italy Salmonella Testing, by Application USD Million (2015-2020)
  • Table 46. United Kingdom Salmonella Testing, by Type USD Million (2015-2020)
  • Table 47. United Kingdom Salmonella Testing, by Application USD Million (2015-2020)
  • Table 48. Netherlands Salmonella Testing, by Type USD Million (2015-2020)
  • Table 49. Netherlands Salmonella Testing, by Application USD Million (2015-2020)
  • Table 50. Rest of Europe Salmonella Testing, by Type USD Million (2015-2020)
  • Table 51. Rest of Europe Salmonella Testing, by Application USD Million (2015-2020)
  • Table 52. MEA Salmonella Testing, by Country USD Million (2015-2020)
  • Table 53. MEA Salmonella Testing, by Type USD Million (2015-2020)
  • Table 54. MEA Salmonella Testing, by Application USD Million (2015-2020)
  • Table 55. Middle East Salmonella Testing, by Type USD Million (2015-2020)
  • Table 56. Middle East Salmonella Testing, by Application USD Million (2015-2020)
  • Table 57. Africa Salmonella Testing, by Type USD Million (2015-2020)
  • Table 58. Africa Salmonella Testing, by Application USD Million (2015-2020)
  • Table 59. North America Salmonella Testing, by Country USD Million (2015-2020)
  • Table 60. North America Salmonella Testing, by Type USD Million (2015-2020)
  • Table 61. North America Salmonella Testing, by Application USD Million (2015-2020)
  • Table 62. United States Salmonella Testing, by Type USD Million (2015-2020)
  • Table 63. United States Salmonella Testing, by Application USD Million (2015-2020)
  • Table 64. Canada Salmonella Testing, by Type USD Million (2015-2020)
  • Table 65. Canada Salmonella Testing, by Application USD Million (2015-2020)
  • Table 66. Mexico Salmonella Testing, by Type USD Million (2015-2020)
  • Table 67. Mexico Salmonella Testing, by Application USD Million (2015-2020)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Salmonella Testing: by Type(USD Million)
  • Table 78. Salmonella Testing Molecular Diagnostics , by Region USD Million (2021-2026)
  • Table 79. Salmonella Testing Monoclonal Antibodies , by Region USD Million (2021-2026)
  • Table 80. Salmonella Testing Immunoassays , by Region USD Million (2021-2026)
  • Table 81. Salmonella Testing Differential Light Scattering , by Region USD Million (2021-2026)
  • Table 82. Salmonella Testing: by Application(USD Million)
  • Table 83. Salmonella Testing Hospitals , by Region USD Million (2021-2026)
  • Table 84. Salmonella Testing Public Health Labs , by Region USD Million (2021-2026)
  • Table 85. Salmonella Testing Physician Offices , by Region USD Million (2021-2026)
  • Table 86. Salmonella Testing Commercial/Private Labs , by Region USD Million (2021-2026)
  • Table 87. South America Salmonella Testing, by Country USD Million (2021-2026)
  • Table 88. South America Salmonella Testing, by Type USD Million (2021-2026)
  • Table 89. South America Salmonella Testing, by Application USD Million (2021-2026)
  • Table 90. Brazil Salmonella Testing, by Type USD Million (2021-2026)
  • Table 91. Brazil Salmonella Testing, by Application USD Million (2021-2026)
  • Table 92. Argentina Salmonella Testing, by Type USD Million (2021-2026)
  • Table 93. Argentina Salmonella Testing, by Application USD Million (2021-2026)
  • Table 94. Rest of South America Salmonella Testing, by Type USD Million (2021-2026)
  • Table 95. Rest of South America Salmonella Testing, by Application USD Million (2021-2026)
  • Table 96. Asia Pacific Salmonella Testing, by Country USD Million (2021-2026)
  • Table 97. Asia Pacific Salmonella Testing, by Type USD Million (2021-2026)
  • Table 98. Asia Pacific Salmonella Testing, by Application USD Million (2021-2026)
  • Table 99. China Salmonella Testing, by Type USD Million (2021-2026)
  • Table 100. China Salmonella Testing, by Application USD Million (2021-2026)
  • Table 101. Japan Salmonella Testing, by Type USD Million (2021-2026)
  • Table 102. Japan Salmonella Testing, by Application USD Million (2021-2026)
  • Table 103. India Salmonella Testing, by Type USD Million (2021-2026)
  • Table 104. India Salmonella Testing, by Application USD Million (2021-2026)
  • Table 105. South Korea Salmonella Testing, by Type USD Million (2021-2026)
  • Table 106. South Korea Salmonella Testing, by Application USD Million (2021-2026)
  • Table 107. Taiwan Salmonella Testing, by Type USD Million (2021-2026)
  • Table 108. Taiwan Salmonella Testing, by Application USD Million (2021-2026)
  • Table 109. Australia Salmonella Testing, by Type USD Million (2021-2026)
  • Table 110. Australia Salmonella Testing, by Application USD Million (2021-2026)
  • Table 111. Rest of Asia-Pacific Salmonella Testing, by Type USD Million (2021-2026)
  • Table 112. Rest of Asia-Pacific Salmonella Testing, by Application USD Million (2021-2026)
  • Table 113. Europe Salmonella Testing, by Country USD Million (2021-2026)
  • Table 114. Europe Salmonella Testing, by Type USD Million (2021-2026)
  • Table 115. Europe Salmonella Testing, by Application USD Million (2021-2026)
  • Table 116. Germany Salmonella Testing, by Type USD Million (2021-2026)
  • Table 117. Germany Salmonella Testing, by Application USD Million (2021-2026)
  • Table 118. France Salmonella Testing, by Type USD Million (2021-2026)
  • Table 119. France Salmonella Testing, by Application USD Million (2021-2026)
  • Table 120. Italy Salmonella Testing, by Type USD Million (2021-2026)
  • Table 121. Italy Salmonella Testing, by Application USD Million (2021-2026)
  • Table 122. United Kingdom Salmonella Testing, by Type USD Million (2021-2026)
  • Table 123. United Kingdom Salmonella Testing, by Application USD Million (2021-2026)
  • Table 124. Netherlands Salmonella Testing, by Type USD Million (2021-2026)
  • Table 125. Netherlands Salmonella Testing, by Application USD Million (2021-2026)
  • Table 126. Rest of Europe Salmonella Testing, by Type USD Million (2021-2026)
  • Table 127. Rest of Europe Salmonella Testing, by Application USD Million (2021-2026)
  • Table 128. MEA Salmonella Testing, by Country USD Million (2021-2026)
  • Table 129. MEA Salmonella Testing, by Type USD Million (2021-2026)
  • Table 130. MEA Salmonella Testing, by Application USD Million (2021-2026)
  • Table 131. Middle East Salmonella Testing, by Type USD Million (2021-2026)
  • Table 132. Middle East Salmonella Testing, by Application USD Million (2021-2026)
  • Table 133. Africa Salmonella Testing, by Type USD Million (2021-2026)
  • Table 134. Africa Salmonella Testing, by Application USD Million (2021-2026)
  • Table 135. North America Salmonella Testing, by Country USD Million (2021-2026)
  • Table 136. North America Salmonella Testing, by Type USD Million (2021-2026)
  • Table 137. North America Salmonella Testing, by Application USD Million (2021-2026)
  • Table 138. United States Salmonella Testing, by Type USD Million (2021-2026)
  • Table 139. United States Salmonella Testing, by Application USD Million (2021-2026)
  • Table 140. Canada Salmonella Testing, by Type USD Million (2021-2026)
  • Table 141. Canada Salmonella Testing, by Application USD Million (2021-2026)
  • Table 142. Mexico Salmonella Testing, by Type USD Million (2021-2026)
  • Table 143. Mexico Salmonella Testing, by Application USD Million (2021-2026)
  • Table 144. Research Programs/Design for This Report
  • Table 145. Key Data Information from Secondary Sources
  • Table 146. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Salmonella Testing: by Type USD Million (2015-2020)
  • Figure 5. Global Salmonella Testing: by Application USD Million (2015-2020)
  • Figure 6. South America Salmonella Testing Share (%), by Country
  • Figure 7. Asia Pacific Salmonella Testing Share (%), by Country
  • Figure 8. Europe Salmonella Testing Share (%), by Country
  • Figure 9. MEA Salmonella Testing Share (%), by Country
  • Figure 10. North America Salmonella Testing Share (%), by Country
  • Figure 11. Global Salmonella Testing share by Players 2020 (%)
  • Figure 12. Global Salmonella Testing share by Players (Top 3) 2020(%)
  • Figure 13. Global Salmonella Testing share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Enzo Biochem (United States) Revenue, Net Income and Gross profit
  • Figure 16. Enzo Biochem (United States) Revenue: by Geography 2020
  • Figure 17. Fujirebio (Belgium) Revenue, Net Income and Gross profit
  • Figure 18. Fujirebio (Belgium) Revenue: by Geography 2020
  • Figure 19. Grifols (Spain) Revenue, Net Income and Gross profit
  • Figure 20. Grifols (Spain) Revenue: by Geography 2020
  • Figure 21. Hologic (United States) Revenue, Net Income and Gross profit
  • Figure 22. Hologic (United States) Revenue: by Geography 2020
  • Figure 23. GSK (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. GSK (United Kingdom) Revenue: by Geography 2020
  • Figure 25. Leica (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Leica (Germany) Revenue: by Geography 2020
  • Figure 27. Eiken Chemical Company Limited (Japan) Revenue, Net Income and Gross profit
  • Figure 28. Eiken Chemical Company Limited (Japan) Revenue: by Geography 2020
  • Figure 29. Romer Labs (Austria) Revenue, Net Income and Gross profit
  • Figure 30. Romer Labs (Austria) Revenue: by Geography 2020
  • Figure 31. Neogen Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Neogen Corporation (United States) Revenue: by Geography 2020
  • Figure 33. Global Salmonella Testing: by Type USD Million (2021-2026)
  • Figure 34. Global Salmonella Testing: by Application USD Million (2021-2026)
  • Figure 35. South America Salmonella Testing Share (%), by Country
  • Figure 36. Asia Pacific Salmonella Testing Share (%), by Country
  • Figure 37. Europe Salmonella Testing Share (%), by Country
  • Figure 38. MEA Salmonella Testing Share (%), by Country
  • Figure 39. North America Salmonella Testing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Enzo Biochem (United States)
  • Fujirebio (Belgium)
  • Grifols (Spain)
  • Hologic (United States)
  • GSK (United Kingdom)
  • Leica (Germany)
  • Eiken Chemical Company Limited (Japan)
  • Romer Labs (Austria)
  • Neogen Corporation (United States)
Select User Access Type

Key Highlights of Report


May 2021 241 Pages 89 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Salmonella Testing Quantitative research analysis
Global Salmonella Testing Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Salmonella Testing Report?

Have a Query? Click Here

Other Related Reports

Facial Aesthetics Comprehensive Study by Type (Dermal Fillers, Botulinum Toxin, Chemical Peel, Microdermabrasion, Hyaluronic acid), Application (Facial Line Correction Treatment, Scar Treatment, Lip ...
$ 3650
Basal Cell Carcinoma Treatment Comprehensive Study by Application (Hospitals, Specialty Clinics, Others), Stages (Stage 0, Stage 1, Stage 2, Stage 3, Stage 4), Treatment Type (Surgery {Surgical Excis...
$ 3750
Pulmonary Drug Delivery Systems Comprehensive Study by Type (Metered Dose Inhalers (Manually-Actuated Pressurized Inhaler, Breath-Actuated Pressurized Inhaler), Dry Powder Inhalers (Single-Dose Inhal...
$ 3750
Blood Culture Test Comprehensive Study by Type (Consumables (Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessori...
$ 3750
Syphilis Testing Comprehensive Study by Type (Treponemal tests, Non-treponemal tests), Syphilis types (Primary Syphilis, Secondary Syphilis, Others (Latent (hidden) stage, Tertiary (late) stage)), G...
$ 3450
Bioactive Wound Management Comprehensive Study by Type (Moist Wound Care, Antimicrobial Wound Care, Others), Application (Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, Bu...
$ 3750